Scleraxis is required for cell lineage differentiation and extracellular matrix remodeling during murine heart valve formation in vivo.
Heart valve structures, derived from mesenchyme precursor cells, are composed of differentiated cell types and extracellular matrix arranged to facilitate valve function. Scleraxis (scx) is a transcription factor required for tendon cell differentiation and matrix organization. This study identified high levels of scx expression in remodeling heart valve structures at embryonic day 15.5 through postnatal stages using scx-GFP reporter mice and determined the in vivo function using mice null for scx. Scx(-/-) mice display significantly thickened heart valve structures from embryonic day 17.5, and valves from mutant mice show alterations in valve precursor cell differentiation and matrix organization. This is indicated by decreased expression of the tendon-related collagen type XIV, increased expression of cartilage-associated genes including sox9, as well as persistent expression of mesenchyme cell markers including msx1 and snai1. In addition, ultrastructure analysis reveals disarray of extracellular matrix and collagen fiber organization within the valve leaflet. Thickened valve structures and increased expression of matrix remodeling genes characteristic of human heart valve disease are observed in juvenile scx(-/-) mice. In addition, excessive collagen deposition in annular structures within the atrioventricular junction is observed. Collectively, our studies have identified an in vivo requirement for scx during valvulogenesis and demonstrate its role in cell lineage differentiation and matrix distribution in remodeling valve structures.
Levay
Agata K
AK
Department of Molecular and Cellular Pharmacology, Leonard M Miller School of Medicine, University of Miami, Miami, FL 33101, USA.
Peacock
Jacqueline D
JD
Lu
Yinhui
Y
Koch
Manuel
M
Hinton
Robert B
RB
Kadler
Karl E
KE
Lincoln
Joy
J
D000375:Aging; D000818:Animals; D051792:Basic Helix-Loop-Helix Proteins / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D002356:Cartilage / Q000196:embryology / Q000378:metabolism; D002454:Cell Differentiation / Q000235:genetics; D019070:Cell Lineage / Q000235:genetics; D003094:Collagen / Q000378:metabolism; D005109:Extracellular Matrix / Q000235:genetics / Q000378:metabolism* / Q000648:ultrastructure; D005355:Fibrosis; D018507:Gene Expression Regulation, Developmental; D005865:Gestational Age; D006023:Glycoproteins / Q000378:metabolism; D049452:Green Fluorescent Proteins / Q000378:metabolism; D006349:Heart Valve Diseases / Q000196:embryology / Q000378:metabolism; D006351:Heart Valves / Q000196:embryology / Q000254:growth & development / Q000378:metabolism* / Q000648:ultrastructure; D008648:Mesoderm / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D038081:Organogenesis / Q000235:genetics; D011994:Recombinant Proteins / Q000378:metabolism
D051792:Basic Helix-Loop-Helix Proteins; D003094:Collagen; D006023:Glycoproteins; D049452:Green Fluorescent Proteins; D011994:Recombinant Proteins; C504563:Col14a1 protein, mouse; C503815:Scx protein, mouse
Dev Dyn. 2000 Apr;217(4):430-9
10767087
Development. 1995 Apr;121(4):1099-110
7743923
Development. 2001 Oct;128(19):3855-66
11585810
Dev Biol. 2002 Jul 15;247(2):351-66
12086472
J Cell Biochem. 2002;87(2):208-20
12244573
Circ Res. 2003 May 2;92(8):827-39
12730128
J Mol Med (Berl). 2003 Jul;81(7):392-403
12827270
Dev Dyn. 2003 Dec;228(4):643-50
14648841
Histol Histopathol. 2004 Apr;19(2):517-25
15024713
Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6502-7
15096597
Dev Dyn. 2004 Jun;230(2):239-50
15162503
J Am Coll Cardiol. 2004 Jul 7;44(1):138-43
15234422
Adv Cardiol. 2004;41:9-15
15285213
Development. 2004 Aug;131(16):3885-96
15253939
Circ Res. 2004 Sep 3;95(5):459-70
15345668
Circ Res. 2004 Sep 17;95(6):645-54
15297379
J Heart Valve Dis. 2004 Sep;13(5):841-7
15473488
J Biol Chem. 1994 Nov 11;269(45):28193-9
7961756
Circulation. 1998 Oct 27;98(17):1699-702
9788821
Nat Genet. 1999 May;22(1):85-9
10319868
Development. 2005 Mar;132(6):1305-14
15716340
Int Rev Cytol. 2005;243:287-335
15797462
Nature. 2005 Sep 8;437(7056):270-4
16025100
Dev Biol. 2005 Oct 1;286(1):299-310
16140292
Heart Fail Rev. 2000 Oct;5(3):239-50
16228907
Nat Clin Pract Cardiovasc Med. 2005 Apr;2(4):209-16
16265485
Mayo Clin Proc. 2006 Jan;81(1):71-6
16438481
Dev Biol. 2006 Apr 15;292(2):292-302
16680829
Circ Res. 2006 Jun 9;98(11):1431-8
16645142
Dev Biol. 2006 Jun 15;294(2):292-302
16643886
J Allergy Clin Immunol. 2006 Jul;118(1):98-104
16815144
Dev Biol. 2006 Oct 1;298(1):234-47
16876153
Dev Biol. 2007 Feb 15;302(2):376-88
17064679
Dev Biol. 2007 May 1;305(1):120-32
17350610
Dev Dyn. 2007 Apr;236(4):971-80
17326134
Dev Dyn. 2007 Jun;236(6):1677-82
17497702
J Biol Chem. 2007 Jun 15;282(24):17665-75
17430895
Development. 2007 Jul;134(14):2697-708
17567668
Circulation. 2008 Jan 29;117(4):e25-146
18086926
J Biol Chem. 2008 May 2;283(18):12129-35
18285337